AU551407B2 - Crystalline human leukocyte interferon - Google Patents
Crystalline human leukocyte interferonInfo
- Publication number
- AU551407B2 AU551407B2 AU91155/82A AU9115582A AU551407B2 AU 551407 B2 AU551407 B2 AU 551407B2 AU 91155/82 A AU91155/82 A AU 91155/82A AU 9115582 A AU9115582 A AU 9115582A AU 551407 B2 AU551407 B2 AU 551407B2
- Authority
- AU
- Australia
- Prior art keywords
- human leukocyte
- leukocyte interferon
- crystalline human
- interferon
- crystalline form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
(For the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) 1. Human leukocyte interferon (IFN-alpha in crystalline form. (For the Contracting State AT) 1. A process for the manufacture of human leukocyte interferon in crystalline form, characterized by treating an aqueous solution of the interferon at a concentration of at least about 0.2 mg/ml with polyethylene glycol (PEG).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32787681A | 1981-12-07 | 1981-12-07 | |
| US327876 | 1981-12-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU9115582A AU9115582A (en) | 1983-06-16 |
| AU551407B2 true AU551407B2 (en) | 1986-05-01 |
Family
ID=23278463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU91155/82A Ceased AU551407B2 (en) | 1981-12-07 | 1982-12-06 | Crystalline human leukocyte interferon |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0083734B1 (en) |
| JP (1) | JPS58164597A (en) |
| AT (1) | ATE18410T1 (en) |
| AU (1) | AU551407B2 (en) |
| CA (1) | CA1209038A (en) |
| DE (1) | DE3269727D1 (en) |
| DK (1) | DK159164C (en) |
| IE (1) | IE54374B1 (en) |
| IL (1) | IL67411A0 (en) |
| NZ (1) | NZ202698A (en) |
| PH (1) | PH20413A (en) |
| ZA (1) | ZA828917B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5441734A (en) * | 1993-02-25 | 1995-08-15 | Schering Corporation | Metal-interferon-alpha crystals |
| CN1245215C (en) | 2001-02-28 | 2006-03-15 | 四川省生物工程研究中心 | Recombinant high-efficiency composite interferon as an inhibitor of hepatitis B surface antigen and e antigen |
| US7585647B2 (en) | 2003-08-28 | 2009-09-08 | Guangwen Wei | Nucleic acid encoding recombinant interferon |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA796175B (en) * | 1978-11-24 | 1980-11-26 | Hoffmann La Roche | Purified proteins and process therefor |
-
1982
- 1982-12-03 AT AT82111201T patent/ATE18410T1/en not_active IP Right Cessation
- 1982-12-03 EP EP82111201A patent/EP0083734B1/en not_active Expired
- 1982-12-03 NZ NZ202698A patent/NZ202698A/en unknown
- 1982-12-03 DK DK538482A patent/DK159164C/en not_active IP Right Cessation
- 1982-12-03 IL IL67411A patent/IL67411A0/en not_active IP Right Cessation
- 1982-12-03 ZA ZA828917A patent/ZA828917B/en unknown
- 1982-12-03 DE DE8282111201T patent/DE3269727D1/en not_active Expired
- 1982-12-06 IE IE2882/82A patent/IE54374B1/en not_active IP Right Cessation
- 1982-12-06 JP JP57213807A patent/JPS58164597A/en active Granted
- 1982-12-06 PH PH28226A patent/PH20413A/en unknown
- 1982-12-06 CA CA000417034A patent/CA1209038A/en not_active Expired
- 1982-12-06 AU AU91155/82A patent/AU551407B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE3269727D1 (en) | 1986-04-10 |
| IL67411A0 (en) | 1983-05-15 |
| JPH0477000B2 (en) | 1992-12-07 |
| AU9115582A (en) | 1983-06-16 |
| ZA828917B (en) | 1983-09-28 |
| IE54374B1 (en) | 1989-09-13 |
| DK159164C (en) | 1991-02-11 |
| DK159164B (en) | 1990-09-10 |
| IE822882L (en) | 1983-06-07 |
| CA1209038A (en) | 1986-08-05 |
| EP0083734A1 (en) | 1983-07-20 |
| JPS58164597A (en) | 1983-09-29 |
| PH20413A (en) | 1987-01-05 |
| NZ202698A (en) | 1986-02-21 |
| ATE18410T1 (en) | 1986-03-15 |
| DK538482A (en) | 1983-06-08 |
| EP0083734B1 (en) | 1986-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU562938B2 (en) | 7, 10, 13, 16 docosatetraenoic acid composition | |
| ZA907338B (en) | Thienylcarboxylates of amino alcohols | |
| NZ217185A (en) | Alleviating cytopathic effects of htlv-iii virus on cells; pharmaceutical composition | |
| JPS6470411A (en) | Drug for oral use | |
| TW272968B (en) | ||
| GR3006807T3 (en) | ||
| DE3462852D1 (en) | Medicament preparation for external use comprising adenosin for the treatment of herpes | |
| AU551407B2 (en) | Crystalline human leukocyte interferon | |
| EP0407815A3 (en) | Polyprenyl compound composition for soft capsules | |
| HUT44126A (en) | Herbicide composition containing pyridine-monocarboxylic acid derivative with sulfur-containing group at the 5th position as active component and process for producing the active component | |
| GR77037B (en) | ||
| ZA892791B (en) | Process for the preparation of 5-chloro-3-chlorosulphonyl-2-thiophenecarboxylic acid esters | |
| EP0464135A4 (en) | Method for reducing side effects of a drug | |
| AU585129B2 (en) | N-tridecyl-2,6-dimethyl-morpholine fluoboric acid salt | |
| EP0215949A4 (en) | Process for preparing 16-substituted prostaglandin e's. | |
| USD267550S (en) | Combination set protractor | |
| EP0410652A3 (en) | Improvement of excretion of potassium ion by prostanoic acid derivatives | |
| AU553275B2 (en) | Stable oxytetracyclin solutions | |
| DE3368628D1 (en) | Process for preparing p.chlorophenoxyacetyl-piperonylpiperazine | |
| ES8606248A1 (en) | Process for the preparation of optically active glycine derivatives. | |
| PT79860A (en) | Process for the preparation of 2-thiazoline and 2-oxozoline with antidote activity against non-selective herbicides |